Skip to main content

Table 2 Relationship between NUSAP1 and clinical data

From: Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors

Clinical parameters

L-NUSAP1 (n = 373, %)

H-NUSAP1 (n = 124, %)

p-value

Age (years)

 < 55

249 (66.8)

83 (66.9)

1

 ≥ 55

124 (33.2)

41 (33.1)

Gender

 Female

271 (72.7)

92 (74.2)

0.816

 Male

102 (27.3)

32 (25.8)

Stage

 I

208 (56.1)

73 (58.9)

0.063

 II

45 (12.1)

6 (4.8)

 III

82 (22.1)

27 (21.8)

 IV

36 (9.7)

18 (14.5)

 NA

2

0

 

Metastasis

 M0

205 (97.2)

71 (95.9)

0.7

 M1

6 (2.8)

3 (4.1)

 NA

162

50

N classification

 N0

182 (54.8)

44 (38.3)

0.002

 N1

150 (45.2)

71 (61.7)

 NA

41

9

T classification

 T1

112 (30.1)

30 (24.4)

0.095

 T2

129 (34.7)

36 (29.3)

 T3

118 (31.7)

48 (39.0)

 T4

13 (3.5)

9 (7.3)

 NA

1

1

 

Pathologic type

 Classical

256 (68.6)

97 (78.2)

0.012

 Follicular

88 (23.6)

14 (11.3)

 Tall cell

23 (6.2)

12 (9.7)

 Others

6 (1.2)

1 (0.2)

BRAF

 Wild-type

150 (41.4)

46 (38.3)

0.592

 Mutated

212 (58.6)

74 (61.7)

 NA

11

4

RAS

 Wild-type

330 (91.2)

113 (94.2)

0.34

 Mutated

32 (8.8)

7 (5.8)

 NA

11

4